MVNOs Capitalizing On Capabilities of MNOs To Reach More Customers

 Mobile virtual network operators (MVNOs) refer to resellers of wireless communication services. These operators lease wireless capacity from third-party mobile network operators (MNOs) at wholesale prices and resell it to customers at lower retail costs under their brand. Since the advent of this technology, MNOs have been increasingly collaborating with MVNOs to optimize the use of their resources and generate more profit. 

Over the years, MVNOs been capitalizing on the consumer acquisition and marketing capabilities of MNOs to increase their wholesale revenue. As MVNOs meet the soaring needs of customers through the optimum use of the existing telecom infrastructure of MNOs, their success largely depends on the value proposition for target customers and unique brand positioning. 

Get the Sample Copy of this Report @ https://www.psmarketresearch.com/market-analysis/mobile-virtual-network-operator-market/report-sample

To attract potential customers, MVNOs are coming up with sharp pricing strategies. Thus, the rising focus of these operators on segment-target pricing will aid the MVNO market to advance at a CAGR of 7.1% during 2021–2031. The market was valued at $66,582.0 million in 2020 and it is projected to reach $139,663.0 million revenue by 2031.

Additionally, the surging adoption of triple-play services will fuel the requirement for MVNOs in the foreseeable future. These services refer to the bundle packs, which include television, latency-sensitive telephone, and broadband internet access services, that are provided by MVNOs to offer better value and retain more consumers. 

These services have been quite successful in North America, particularly in the U.S. In the coming years, triple-play services will be available across the world through the internet. This market research report provides a comprehensive overview of the market

• Future potential of the market through its forecast for the period 2020– 2030
• Major factors driving the market and their impact during the short, medium, and long terms
• Market restraints and their impact during the short, medium, and long terms
• Recent trends and evolving opportunities for the market participants
• Historical and the present size of the market segments and understand their comparative future potential
• Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings

Read More

What are Major Factors Fuelling the Boom of Dental Implants and Prostheses Market in Asia-Pacific (APAC)?

One of the major factors fuelling the growing demand for dental implants and prostheses is the rising prevalence of oral health problems across the world. Since the last few years, there has been a massive surge in the incidence of oral health problems such as periodontal diseases, tooth decay, tooth sensitivity problems, and tooth erosion in many countries around the world. As per the Centers for Disease Control and Prevention (CDC), around 84.7% of the children in the U.S. in the age group 2–17 years visited dentists because of oral health problems in 2014.

The other major factor pushing the demand for dental implants and prostheses is the surging geriatric population across the globe. The elderly people are more susceptible to dental problems owing to the fact that the condition of the teeth including the tooth enamel starts deteriorating with increasing age. As per the United Nations Department of Economic and Social Affairs (UNDESA) report on the global geriatric population, the population of the people aged 60 years and above increased from 382 million to 962 million from 1980 to 2017, and this number is predicted to further rise to 2.1 billion by 2051.

The Asia-Pacific (APAC) region is expected to register the fastest growth in the utilization of dental implants and prostheses in the coming years. This is mainly ascribed to the rising prevalence of dental problems, increasing dental tourism, and soaring awareness amongst the people about dental care, in this region. In addition to this, the surging geriatric population in China and India is further contributing to the growing demand fordental implants and prostheses in the APAC region.

Hence, it can be undoubtedly said that due to the increasing incidence of dental and oral health problems and increasing geriatric population, the demand for dental implants and prostheses will shoot-up across the world in the coming years.

Read More

Growing Diabetes Prevalence Fueling Insulin Delivery Device Sales

The rising incidence of diabetes, on account of the growing prevalence of obesity, is pushing up the demand for insulin delivery devices. As per the World Health Organization (WHO), nearly 2.8 million deaths are recorded every year because of obesity and around 44% of the diabetes cases across the world are caused because of excess weight or obesity. Furthermore, the organization reported that the incidence of obesity increased nearly three-fold between 1975 and 2016.

Additionally, around 13% of the global adult population (15% of women and 11% of men) was obese in 2016, and over 1.9 billion adults in the age bracket- 18 years and older- were overweight in 2016. Out of these, more than 650 million adults were obese. As obesity makes a person highly vulnerable to diabetes, its growing incidence is propelling the demand for insulin delivery devices. Diabetic people don’t have a stable blood glucose level and thus, need insulin therapy.

The therapy is used for managing both type 1 and type 2 diabetes. Besides, the surging geriatric population in several countries is also driving the worldwide demand for insulin delivery devices, as geriatric people are highly susceptible to diabetes. This is, in turn, fueling the growth of the global insulin delivery device market. According to the forecast of the market research company, P&S Intelligence, the market will advance at a CAGR of 6.6% between 2016 and 2022.

Pumps, syringes, and pens are the most widely used types of insulin delivery devices across the world. Out of these, the demand for pumps is predicted to surge sharply in the coming years. Geographically, the sales of insulin delivery devices were observed to be the highest in North America in the years gone by. Europe recorded the second-highest sales of these devices across the globe during the last few years.

Read More

Molecular Cytogenetics Market to Witness Robust Growth in Coming Years

The increasing incidence of cancer is one of the biggest factors responsible for the growing demand for molecular cytogenetics methods. This is because various molecular cytogenetics methods are heavily adopted for cancer diagnostic purposes. Besides this, the surging number of cancer research projects being conducted in several countries is also fueling the demand for molecular cytogenetics, on account of the fact that advanced methods are required for gaining a better understanding of the disease at the chromosomal level.

The growing popularity of genetic-based prediction and estimation of various chromosomal abnormalities, the surging population of geriatric people and their susceptibility to chronic ailments, and the rising usage of molecular cytogenetics in crop improvement are the other important factors adding wings to the molecular cytogenetics demand across the globe. This is, in turn, fueling the boom of the global molecular cytogenetics market. The market is predicted to progress at a CAGR of 9.9% from 2018 to 2023.

Furthermore, according to the forecast of P&S Intelligence, a market research company based in India, the value of the market would grow from $1.8 billion to $3.3 billion from 2017 to 2023. Based on technology, molecular cytogenetics is divided into karyotyping, immunohistochemistry (IHC), fluorescence in-situ hybridization (FISH), and comparative genomic hybridization (CGH). Amongst these, the demand for the FISH technology is expected to rise enormously over the next few years.

Thus, it is safe to say that the demand for molecular cytogenetics would skyrocket around the world in the forthcoming years, mainly because of the growing incidence of cancer and rapid technological advancements and innovations in medical research and disease diagnosis and prognosis processes. 

Read More

How is Western Influence Driving Skincare Devices Market?

 The prevalence of skin-related disorders and skin cancer has been rising since the past few years. As per the WHO, approximately 132,000 cases of melanoma and about 2–3 million cases of non-melanoma skin cancer affect people across the globe every year. Other than this, increased anxiety, stress, tobacco & alcohol consumption, pollution, UV exposure, and unfavorable environmental conditions are leading to the high prevalence skin diseases. Owing to these factors, the demand for skincare devices has also been rising across the globe. 

Attributed to this, manufacturers are also focusing on manufacturing easy-to-use products that can be operated easily at home without needing any technical expertise. Electronics skincare devices, which provide enhanced automation convenience, and consume less time, are being introduced in the market. The increased adoption of these devices in the coming years is expected to result in the growth of the market. Skincare devices can be diagnostic or treatment devices, between which, the demand for treatment devices was higher in the past. 

Out of these, the demand for skincare devices is expected to increase considerably for the skin tightening & body contouring application in the coming years. The prevalence of obesity is surging across the globe, along with the number of people undergoing liposuction, which is creating high requirement for skin tightening. Apart from this, the demand for skincare devices has also been high for the hair removal application in the past, owing to the rising awareness regarding laser hair removal devices among people. The expanding e-commerce industry is also resulting in increasing adoption of home-use hair removal devices. 

Geographically, the skincare devices market is being dominated by North America, owing to the high healthcare expenditure, rising awareness regarding skin problems and their treatment, and increasing per capita income of people. Furthermore, the rising availability of health coverage for skin cancer via Medicaid and Medicare in the U.S. is also resulting in the growth of the regional domain. The Asia-Pacific region is projected to create significant demand for skincare devices in the coming years. 

Read More

Neurostimulation Devices Providing Immediate Relief by Blocking Pain Signals

As per the Parkinson’s Disease Foundation, about 7–10 million people suffer from Parkinson’s disease, globally. In the U.S., each year, 60,000 new cases of Parkinson’s disease are reported. Further, epilepsy is one of the most common neurological disorders and affects people of all age groups.

The World Health Organization said that about 50 million people across the world suffer from epilepsy, and about 2.4 million people are diagnosed with the condition every year. Chronic pain is associated with these diseases and many other conditions and may even be a result of injuries, which greatly affects the way of life. In a study conducted by the International Association for the Study of Pain, it was reported that about 2.8% of the total diabetic population suffered from peripheral neuropathic pain in 2000, and it is predicted to grow to 4.4% by 2030.

Download Sample of This Research Report: 

The demand for these devices was the highest in North America among all the regions, namely Asia, Europe, and Rest of the World. This was attributed to the surging geriatric population and the growing incidence of neurological disorders in the region. Further, the popularity of minimally invasive treatment and the increasing research & development activities in the development of innovative neurostimulation devices have been instrumental in driving the regional market forward. The neurostimulation device market is expected to register a 12.9% CAGR during 2016–2022.

Chronic pains more commonly affect nerves, bones, and the back. These pains can be debilitating, and to treat them, neurostimulation devices are used. These devices work by generating mild electric signals that reach the brain faster than pain signals, and trick the patient into feeling the tingling sensation instead of pain, they block pain signals before they reach the brain, thereby providing relief to patients. Some common pain management devices available in the neurostimulation device market are peripheral nerve stimulation device and SCS device.

Read More

Historical and Current Trends of Human Insulin Market Size in Terms of Volume and Value

On account of the growing number of diabetic patients, increasing geriatric population, technological advancements in insulin delivery devices, and rising population exposed to risk factors are leading to the growth of the human insulin market. The global market generated a revenue of $42.9 billion in 2017, and it is expected to witness a CAGR of 8.8% during the forecast period (2018–2023). Human insulin (HI) is synthetic insulin, which mimics the effects and functionality of natural insulin in humans. It is generally created by growing the insulin protein in the E. coli bacteria.

In a recent P&S Intelligence research, the human insulin market is segmented by type, application, and region. Under the product segment, the market is further divided into HI drugs and delivery devices. Due to increase in research and development  activities for drugs discovery and manufacture, and high prevalence of diabetes, HI drugs held the larger share (79.5%) in the market in 2017 in terms of value. Furthermore, the rise in geriatric population and growth in demand for HI analogs is also pushing the market progress; analogs and biologics are two categories of the HI drugs division.

Download Sample of This Research Report:

Globally, North America dominated the human insulin market in 2017 with 39.2% revenue share. An increase in the number of diabetes patients contributed in the growth of the domain. The number of diabetic patients had grown from 108 million to 422 million between 1980 and 2014, and this number is anticipated to reach 592 million by 2035. As per the International Diabetes Federation, in 2017, 425 million people aged 20–79 across the globe had diabetes, and this number is projected to reach 629 million by 2045.

Therefore, it is apparent that the steady growth of the market will give players lucrative opportunities to invest in the research and development of improved insulin drugs and delivery systems.

Read More..

Read More